Staloral (allergy immunotherapy sublingual) / Stallergenes 
Welcome,         Profile    Billing    Logout  
 19 Diseases   5 Trials   5 Trials   30 News 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Staloral (allergy immunotherapy sublingual) / Stallergenes
2014-003204-70: Pilot study on asthma control in patients with grass- pollen allergic rhinitis treated with 5 grass-pollen sublingual immunotherapy (Staloral®) vs placebo Estudio piloto sobre el control del asma en pacientes con rinitis alérgica a polen de gramíneas tratados con inmunoterapia sublingual de 5 gramíneas (Staloral®) vs placebo

Ongoing
4
74
Europe
Sublingual spray, solution, Staloral Pollens maintenance 300 IR/ml sublingual solution
Dr. Javier Domínguez Ortega, STALLERGENES IBERICA S.A.
Respiratory Allergy: Asthma and allergic rhinitis due to grass pollen Alergia respiratoria: Asma y rinitis alérgicas por polen de gramíneas, Respiratory Allergy Alergia respiratoria, Diseases [C] - Respiratory Tract Diseases [C08]
 
 
2013-000492-32: The effect of allergen and virus on tonsillar cell function Allergeenin ja viruksen vaikutus nielurisan solujen toimintaan

Ongoing
4
120
Europe
Grazax, Fluenz, Staloral® -birch, Grazax, Fluenz, Staloral® -birch
Turku University Hospital
We investigate the effects of allergen and virus on patients with recurrent tonsillitis or tonsillar hypertrphy. Tutkimme allergeenin ja viruksen vaikutuksia potilailla, joilla on joko toistuva tonsilliitti tai tonsillojen hypertrofia.
 
 
2012-005678-76: SUBLINGUAL IMMUNOTHERAPY IN PEDIATRIC ASTHMA Immunoterapia sublinguale nell'asma pediatrico

Ongoing
3
170
Europe
Staloral 300 acari, Sublingual solution of HDM Allergen Extracts, Oral drops
ALLEGRIA onlus, AIFA
Allergic asthma to house dust mites Asma allergico agli acari della polvere, Allergic asthma Asma allergico, Diseases [C] - Respiratory Tract Diseases [C08]
 
 
2016-002844-18: Prevention of allergy development in preschool children

Ongoing
3
96
Europe
Staloral house dust mite, ALL-0012 A66 ALL-0012 A67, Sublingual spray, solution, Staloral - house dust mite
Medical University of Vienna, Dpt. of Pediatrics, Medical University of Vienna, Dpt. of Pediatrics
Patients; children at age 4 years with house dust mite IgE sensitization without allergic disease, In order to prevent the development of allergic diseases in children sensitized to house dust mite a preventive immunotherapy trial will be applied., Diseases [C] - Immune System Diseases [C20]
 
 
YOBI, NCT05668390 / 2022-002012-23: Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma

Active, not recruiting
3
699
Europe
STALORAL® Birch 300 IR
Stallergenes Greer, STALLERGENES
Allergic Rhinoconjunctivitis, Birch Pollen Allergy
07/25
11/25

Download Options